You are here

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
696 Brentuximab vedotin, a CD30-directed antibody-drug conjugate, selectively depletes activated Tregs in vitro and in vivo

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020163017
Dec 20202205
Jan 20211603
Feb 202146017
Mar 202170017
Apr 202190011
May 202125012
Jun 20210010
Jul 2021106
Aug 20210010
Sep 20210010
Oct 202164024
Nov 202168030
Dec 20213008
Jan 20222203
Feb 20222209
Mar 20222806
Apr 20225608
May 20224604
Jun 202240011
Jul 20225207
Aug 202234013
Sep 20224001
Oct 20224603
Nov 20221604
Dec 20222802
Jan 20235809
Feb 20233204
Mar 202354017
Apr 202342018
May 20234204
Jun 20233401
Jul 20233805
Aug 20232603
Sep 20234008
Oct 20231803
Nov 20233201
Dec 20232000
Jan 2024602
Feb 20242401
Mar 20243602
Apr 20245406
May 20245203
Jun 20245408
Jul 20243003
Aug 20244404
Sep 20243606
Oct 20246406
Nov 20243605
Dec 202446012
Jan 20252605
Feb 2025802
Mar 2025008
Apr 2025003
May 2025006
Jun 2025002
Total19770408